Literature DB >> 29377520

Comparative Pharmacological Study of Common NMDA Receptor Open Channel Blockers Regarding Their Affinity and Functional Activity toward GluN2A and GluN2B NMDA Receptors.

Louisa Temme1, Dirk Schepmann1, Julian A Schreiber1, Bastian Frehland1, Bernhard Wünsch1,2.   

Abstract

Because only a few studies have investigated the affinity and functional activity of NMDA receptor open channel blockers under the same assay conditions, a comparative study of common open channel blockers is of major interest. The pharmacological activities of MK-801, phencyclidine (PCP), dexoxadrol, etoxadrol, (S)- and (R)-ketamine, dextromethorphan, memantine, and amantadine were analyzed under uniform assay conditions. Affinity toward the PCP and ifenprodil binding sites was recorded in radioligand binding assays. GluN2A and GluN2B subtype-specific cytoprotective activity was determined in lactate dehydrogenase (LDH) assays. The data were correlated with published IC50 values obtained in two-electrode voltage clamp experiments. A high correlation was found between PCP affinity, ion flux inhibition, and cytoprotective activity. The channel blockers were classified into four groups showing high, moderate, low, and very low potency. Some of the open channel blockers display unexpected subtype selectivity. The comparative study allows the characterization of open channel blockers from their receptor ligand interaction via inhibition of ion flux up to overall cytoprotective activity. The subtype preference of some open channel blockers will stimulate the development of novel subtype-selective open channel blockers with decreased side effect potential.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  GluN2A; GluN2B; NMDA receptors; cytoprotection; open channel blockers; subtype selectivity

Mesh:

Substances:

Year:  2018        PMID: 29377520     DOI: 10.1002/cmdc.201700810

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  5 in total

1.  Extremely low frequency magnetic field induces human neuronal differentiation through NMDA receptor activation.

Authors:  Alp Özgün; Ana Marote; Leo A Behie; António Salgado; Bora Garipcan
Journal:  J Neural Transm (Vienna)       Date:  2019-07-17       Impact factor: 3.575

Review 2.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

3.  The Effect of Intrathecal Injection of Dextromethorphan on the Experimental Neuropathic Pain Model.

Authors:  Achmad Fahmi; Yunus Kuntawi Aji; Dirga Rachmad Aprianto; Akbar Wido; Asadullah Asadullah; Nurkholis Roufi; Danti Nur Indiastuti; Heri Subianto; Agus Turchan
Journal:  Anesth Pain Med       Date:  2021-06-29

Review 4.  Protein quality control of N-methyl-D-aspartate receptors.

Authors:  Taylor M Benske; Ting-Wei Mu; Ya-Juan Wang
Journal:  Front Cell Neurosci       Date:  2022-07-22       Impact factor: 6.147

Review 5.  Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?

Authors:  Tetsuro Kikuchi
Journal:  Biomolecules       Date:  2020-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.